Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of LANDI-Amlodipine vs Norvasc in Healthy Volunteers
NCT02974439Phase 1Completed
- Sponsor
- Shanghai Haini Pharmaceutical Co., Ltd.
- Start
- Dec 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of amlodipine in hypertension (HTN) (2 arms), sponsored by Shanghai Haini Pharmaceutical Co., Ltd. Primary endpoint: Peak Plasma Concentration at 144 hours. Started Dec 2016; status: completed.
02
Drugs
amlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02974439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02974439.